Heather Webber
The University of Texas Health Science Center, Houston
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Heather Webber as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:56 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06712446 · A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use DisorderThe University of Texas Health Science Center, Houston · completed · Methamphetamine Use Disorder · principal investigator
- Ph2NCT06444256 · Orexin Receptor Antagonism and Sleep in Stimulant Use DisorderThe University of Texas Health Science Center, Houston · recruiting · Stimulant Use Disorder · principal investigator
- N/ANCT05986578 · Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use DisorderThe University of Texas Health Science Center, Houston · recruiting · Cocaine Use Disorder · principal investigator
- Ph2NCT05711862 · The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use DisorderThe University of Texas Health Science Center, Houston · terminated · Methamphetamine Use Disorder · principal investigator
- N/ANCT05631548 · Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder (Pilot Study)The University of Texas Health Science Center, Houston · completed · Cocaine Use Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use DisorderK01DA058765 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 2023 to 2026 · $192,093 awarded in 2026Grant number is on one of their registry trials
- Contingency management plus deep transcranial magnetic stimulation for the treatment of cocaine use disorderU01DA064181 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 2025 · $3,119,619 awarded in 2025Same name and institution; not confirmed by an ID
- Using event-related potentials to predict treatment outcomes in cocaine use disorderF32DA048542 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 2020 to 2021 · $68,562 awarded in 2021Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:56 UTC. The ranking covers the 200 most relevant of 8 PubMed records, and a shared surname and initials can bring in a namesake. All 8 on PubMed
- Contingency management plus acceptance and commitment therapy for initial cocaine abstinence: Results of a sequential multiple assignment randomized trial (SMART).Drug Alcohol Depend · 202410 citationsRCR 3.1
- Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women.Psychopharmacology (Berl) · 20227 citationsRCR 0.8
- The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis.Drug Alcohol Depend · 20215 citationsRCR 0.5
- Acute drug effects differentially predict desire to take dextroamphetamine again for work and recreation.Psychopharmacology (Berl) · 20214 citationsRCR 0.3
- Cocaine-specific speed-accuracy trade-off during anti-saccade testing differentiates patients with cocaine use disorder who achieve initial abstinence during treatment.J Psychopharmacol · 20212 citationsRCR 0.2
- The role of Iowa gambling task performance in response to citalopram treatment for cocaine use disorder.Am J Drug Alcohol Abuse · 20251 citationsRCR 0.7
- Anti-saccade error rates are associated with somatic depressive symptoms in cocaine use disorder.J Psychopharmacol · 20250 citationsRCR 0.0